AWARD
A -- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
- Notice Date
- 9/25/2015
- Notice Type
- Award Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- N01CN5500347
- Archive Date
- 10/7/2015
- Point of Contact
- Nicole Belanger, Phone: 3016248754
- E-Mail Address
-
belangern@mail.nih.gov
(belangern@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- Below
- Award Date
- 9/22/2015
- Awardee
- See description
- Award Amount
- Maximum value of $19,800,000
- Description
- Multiple Award IDIQ to the following contractors: HHSN261201500032I, The Research Institute of Fox Chase Cancer Center HHSN261201500041I, SRI International HHSN261201500042I, IIT Research Institute HHSN261201500018I, University of Texas MD Anderson Cancer Center HHSN261201500036I, University of Alabama at Birmingham HHSN261201500037I, Medical College of Wisconsin HHSN261201500038I, University of Oklahoma Health Sciences Center HHSN261201500039I, Weill Medical College of Cornell University
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF2/Awards/Below.html)
- Record
- SN03904454-W 20150927/150925235703-923154704feb0f790c269bab7aa5eb07 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |